适应性阶段跟踪系统的帕金森休息震动:设计和临床可行性
Beatriz S Arruda1, Moaad Benjaber2,3,4, John Fleming2,3,4
1Department of Clinical and Movement NeurosciencesQueen Square Institute of Neurology, University College London London WC1N 3BG U.K.
IEEE journal of translational engineering in health and medicine
|November 12, 2025
概括
一个新的可穿戴系统准确地实时跟踪帕金森病 (PD) 的震阶段. 这种适应性技术为个性化,非侵入性疗法提供了基础,以管理震变异性.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 临床研究 临床研究
背景情况:
- 震是一种常见的运动障碍,通常与帕金森病 (PD) 相关.
- 目前对PD震的治疗方法,包括药物治疗和深度大脑刺激,都有局限性.
- 对于PD震管理的非侵入性治疗替代方案有很大的需求.
研究的目的:
- 开发和验证一个用于实时估计帕金森症休息震阶段的手腕穿戴系统.
- 创建一种可适应的算法,能够处理PD患者的震变异性.
- 为个性化,非侵入性的震管理策略奠定基础.
主要方法:
- 开发了一个带有可适应相位跟踪算法的手腕穿戴系统.
- 算法动态调整到震动轴和中心频率的变化.
- 该系统经过了离线验证和临床可行性测试,在三名PD参与者身上进行了电刺激.
主要成果:
- 该系统在离线和所有参与者中都展示了强大的相位估计.
- 该算法成功地适应了特征的动态变化.
- 个性化的刺激设置导致了适度的震调制.
结论:
- 这项研究为PD的震阶段跟踪研究提供了一个新的平台.
- 开发的可穿戴系统可以解释PD震的变化.
- 这项工作为个性化,非侵入性的震管理策略奠定了基础.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.9K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.2K
相关概念视频
01:24Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K